Meng-Chih Lin

1.0k citations
24 papers · 742 indexed · h-index 15
Topics
SARS-CoV-2 and COVID-19 Research (6 papers)COVID-19 Clinical Research Studies (6 papers)Respiratory Support and Mechanisms (5 papers)
Partner nations
TaiwanUnited StatesJapan

In The Last Decade

Meng-Chih Lin

23 papers receiving 724 citations

Peers

Meng-Chih Lin
Comparison fields: 5 of 95
  • Pulmonary and Respiratory Medicine 255
  • Oncology 170
  • Infectious Diseases 151
  • Epidemiology 142
  • Physiology 142
Replace F. Capote with:
F. Capote Spain
Hans Hockey New Zealand
Alireza Fatemi Iran
Gidon Berger Israel
Masoud Nouri‐Vaskeh Iran
Funda Çoşkun Türkiye
Aliaë Mohamed-Hussein Egypt
Meizhu Chen China
Varsha Taskar United States
Diana Manolescu Romania
Meng-Chih Lin relative to F. Capote Spain F. Capote's profile →
Citations per field
00.5×10×13×
F. Capote · 1×
Citations per year

Countries citing papers authored by Meng-Chih Lin

Since Specialization
Citations

This map shows the geographic impact of Meng-Chih Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meng-Chih Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meng-Chih Lin more than expected).

Fields of papers citing papers by Meng-Chih Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Meng-Chih Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meng-Chih Lin. The network helps show where Meng-Chih Lin may publish in the future.

Co-authorship network of co-authors of Meng-Chih Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Meng-Chih Lin. A scholar is included among the top collaborators of Meng-Chih Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Meng-Chih Lin. Meng-Chih Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 10
3 1
4 6
5 8
6 12
7 13
8 2
9 20
10 14
11 21
12 36
13 59
14 103
15 2
16 20
17 24
18 62
19 27
20 23

About Meng-Chih Lin

Meng-Chih Lin is a scholar working on Family Practice, Infectious Diseases and Molecular Medicine, having authored 24 papers that have together received 742 indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (6 papers), COVID-19 Clinical Research Studies (6 papers) and Respiratory Support and Mechanisms (5 papers). The work is most often cited by research in Endocrine and Autonomic Systems (84 citations), Critical Care and Intensive Care Medicine (64 citations) and Ophthalmology (86 citations). Meng-Chih Lin has collaborated with scholars based in Taiwan, United States and Japan. Frequent co-authors include Chong‐Jen Yu, Michael Friedman, Hsin-Ching Lin, Meghan Wilson, Hsueh-Wen Chang, Jien-Wei Liu, Chih‐Yen Tu, Tony Mok, Jong-Seok Lee and Myung‐Ju Ahn. Their work appears in journals such as The Journal of Immunology, Radiology and SLEEP.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026